Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic
Market Cap
$208.83 Million
CN¥1.53 Billion CNY
Market Cap Rank
#17590 Global
#4550 in China
Share Price
CN¥2.61
Change (1 day)
-5.09%
52-Week Range
CN¥2.61 - CN¥5.58
All Time High
CN¥24.91
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the… Read more

Qinghai Spring Medicinal Resources Technology Co Ltd (600381) - Net Assets

Latest net assets as of September 2025: CN¥1.03 Billion CNY

Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has net assets worth CN¥1.03 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.08 Billion) and total liabilities (CN¥45.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥1.03 Billion
% of Total Assets 95.8%
Annual Growth Rate 9.68%
5-Year Change -49.92%
10-Year Change -41.07%
Growth Volatility 162.73

Qinghai Spring Medicinal Resources Technology Co Ltd - Net Assets Trend (1998–2024)

This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2024)

The table below shows the annual net assets of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2024.

Year Net Assets Change
2024-12-31 CN¥1.04 Billion -18.23%
2023-12-31 CN¥1.27 Billion -17.33%
2022-12-31 CN¥1.53 Billion -15.80%
2021-12-31 CN¥1.82 Billion -12.02%
2020-12-31 CN¥2.07 Billion -13.38%
2019-12-31 CN¥2.39 Billion +0.24%
2018-12-31 CN¥2.38 Billion +2.71%
2017-12-31 CN¥2.32 Billion +15.78%
2016-12-31 CN¥2.00 Billion +13.96%
2015-12-31 CN¥1.76 Billion +470.08%
2014-12-31 CN¥308.44 Million +516.46%
2013-12-31 CN¥50.03 Million -97.68%
2012-12-31 CN¥2.15 Billion -7.16%
2011-12-31 CN¥2.32 Billion +2096.55%
2010-12-31 CN¥-116.10 Million +34.82%
2009-12-31 CN¥-178.12 Million +22.83%
2008-12-31 CN¥-230.81 Million +36.31%
2007-12-31 CN¥-362.40 Million +15.64%
2006-12-31 CN¥-429.60 Million -231.07%
2005-12-31 CN¥327.77 Million -33.07%
2004-12-31 CN¥489.71 Million +25.04%
2003-12-31 CN¥391.64 Million +11.33%
2002-12-31 CN¥351.79 Million +5.33%
2001-12-31 CN¥333.98 Million +183.52%
2000-12-31 CN¥117.80 Million +3.90%
1999-12-31 CN¥113.38 Million +20.79%
1998-12-31 CN¥93.87 Million --

Equity Component Analysis

This analysis shows how different components contribute to Qinghai Spring Medicinal Resources Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 13548991693.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥135.28 Million 13.10%
Common Stock CN¥587.06 Million 56.86%
Other Comprehensive Income CN¥106.58 Million 10.32%
Other Components CN¥203.63 Million 19.72%
Total Equity CN¥1.03 Billion 100.00%

Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Market Cap

The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their market capitalization.

Company Market Cap
GZ4
F:GZ4
 		$116.32 Million
Unicycive Therapeutics Inc
NASDAQ:UNCY
 		$116.32 Million
CTT Systems AB
ST:CTT
 		$116.33 Million
Kuo Yang Construction Co Ltd
TW:2505
 		$116.40 Million
Forest Packaging Group Co Ltd
SHG:605500
 		$116.30 Million
MK Electron Co. Ltd
KQ:033160
 		$116.29 Million
Qijing Machinery
SHG:603677
 		$116.25 Million
Enli Technology Co.,Ltd
TWO:7728
 		$116.23 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Qinghai Spring Medicinal Resources Technology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,265,066,305 to 1,032,551,890, a change of -232,514,415 (-18.4%).
  • Net loss of 198,766,233 reduced equity.
  • Share repurchases of 33,748,180 reduced equity.
  • Other comprehensive income increased equity by 106,583,374.
  • Other factors decreased equity by 106,583,376.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-198.77 Million -19.25%
Share Repurchases CN¥33.75 Million -3.27%
Other Comprehensive Income CN¥106.58 Million +10.32%
Other Changes CN¥-106.58 Million -10.32%
Total Change CN¥- -18.38%

Book Value vs Market Value Analysis

This analysis compares Qinghai Spring Medicinal Resources Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.48x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 3.47x to 1.48x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1998-12-31 CN¥0.75 CN¥2.61 x
1999-12-31 CN¥0.88 CN¥2.61 x
2000-12-31 CN¥0.90 CN¥2.61 x
2001-12-31 CN¥2.63 CN¥2.61 x
2002-12-31 CN¥2.72 CN¥2.61 x
2003-12-31 CN¥2.94 CN¥2.61 x
2004-12-31 CN¥3.08 CN¥2.61 x
2005-12-31 CN¥1.78 CN¥2.61 x
2006-12-31 CN¥-3.50 CN¥2.61 x
2007-12-31 CN¥-3.03 CN¥2.61 x
2008-12-31 CN¥-2.16 CN¥2.61 x
2009-12-31 CN¥-1.75 CN¥2.61 x
2010-12-31 CN¥-0.81 CN¥2.61 x
2011-12-31 CN¥7.52 CN¥2.61 x
2012-12-31 CN¥7.02 CN¥2.61 x
2013-12-31 CN¥-0.17 CN¥2.61 x
2014-12-31 CN¥0.50 CN¥2.61 x
2015-12-31 CN¥2.75 CN¥2.61 x
2016-12-31 CN¥3.18 CN¥2.61 x
2017-12-31 CN¥3.95 CN¥2.61 x
2018-12-31 CN¥4.17 CN¥2.61 x
2019-12-31 CN¥4.07 CN¥2.61 x
2020-12-31 CN¥3.52 CN¥2.61 x
2021-12-31 CN¥3.10 CN¥2.61 x
2022-12-31 CN¥2.61 CN¥2.61 x
2023-12-31 CN¥2.17 CN¥2.61 x
2024-12-31 CN¥1.77 CN¥2.61 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Qinghai Spring Medicinal Resources Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -19.25%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -73.55%
  • • Asset Turnover: 0.23x
  • • Equity Multiplier: 1.13x
  • Recent ROE (-19.25%) is below the historical average (-0.61%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1998 10.36% 7.49% 0.61x 2.27x CN¥337.40K
1999 14.17% 16.70% 0.38x 2.21x CN¥4.56 Million
2000 15.65% 16.92% 0.34x 2.71x CN¥6.37 Million
2001 5.93% 13.62% 0.24x 1.82x CN¥-13.35 Million
2002 6.09% 6.81% 0.39x 2.26x CN¥-13.24 Million
2003 7.52% 6.22% 0.38x 3.22x CN¥-9.10 Million
2004 4.91% 1.90% 0.58x 4.46x CN¥-19.55 Million
2005 -72.08% -27.40% 0.43x 6.17x CN¥-182.59 Million
2006 0.00% -646.14% 0.20x 0.00x CN¥-514.68 Million
2007 0.00% 528.31% 0.03x 0.00x CN¥89.36 Million
2008 0.00% 287.43% 0.11x 0.00x CN¥144.01 Million
2009 0.00% 97.04% 0.15x 0.00x CN¥73.20 Million
2010 0.00% 87.31% 0.07x 0.00x CN¥68.54 Million
2011 4.80% 38.78% 0.06x 2.04x CN¥-100.26 Million
2012 -7.41% -25.91% 0.13x 2.25x CN¥-313.07 Million
2013 0.00% 788.49% 0.00x 0.00x CN¥36.28 Million
2014 32.69% 265.38% 0.02x 5.91x CN¥55.08 Million
2015 20.38% 25.51% 0.66x 1.20x CN¥182.10 Million
2016 12.25% 34.59% 0.32x 1.11x CN¥44.99 Million
2017 13.41% 65.92% 0.19x 1.05x CN¥79.01 Million
2018 2.88% 20.55% 0.14x 1.02x CN¥-169.54 Million
2019 0.24% 2.48% 0.10x 1.01x CN¥-233.06 Million
2020 -15.44% -257.14% 0.06x 1.07x CN¥-526.45 Million
2021 -13.66% -194.59% 0.07x 1.02x CN¥-430.66 Million
2022 -18.76% -179.52% 0.10x 1.02x CN¥-440.84 Million
2023 -21.17% -125.24% 0.16x 1.07x CN¥-394.37 Million
2024 -19.25% -73.55% 0.23x 1.13x CN¥-302.02 Million

Industry Comparison

This section compares Qinghai Spring Medicinal Resources Technology Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,123,990,643
  • Average return on equity (ROE) among peers: -0.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) CN¥1.03 Billion 10.36% 0.04x $116.31 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $702.18 Million
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million